Literature DB >> 20868578

A possible decline in the incidence and severity of Behçet's disease: implications for an infectious etiology and oral health.

Haner Direskeneli1, Gonca Mumcu.   

Abstract

Behçet's disease (BD) is a systemic and inflammatory disorder mainly present along the ancient Silk Road, from the Mediterranean to East Asia. A wide range of prevalence figures (0.1-420/100.000) are reported for BD, also among populations of similar ethnicity living in different countries. Recently, a decline of the incidence of BD and a change of the disease spectrum to less severe mucocutaneous manifestations is reported from Japan, a genetically homogenous, affluent population with limited immigration. Among environmental factors, a change in atopy/allergic disorders and a decline in infections are two possible mechanisms for this epidemiological change. A shift in Th1/Th2 immune balance towards Th2-associated immune responses are possible, however 'hygiene hypothesis' associated with this approach does not explain the recent trend of the increase in Th1-associated disorders such as inflammatory bowel disease and multiple sclerosis in Western Countries. We hypothesise that a decline in oral infections, associated with the improvement in oral health in Japan, could be behind this decline. Better epidemiological studies in other populations will show whether this decline is a worldwide trend and may provide a better understanding of the environmental factors associated with the onset or relapses of BD, leading a way to new therapeutic approaches.

Entities:  

Mesh:

Year:  2010        PMID: 20868578

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  [Update: Behçet's disease].

Authors:  I Kötter
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

2.  Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.

Authors:  Cemile Sonmez; Aysegul Atak Yucel; Turan Hilmi Yesil; Hamit Kucuk; Berna Sezgin; Ridvan Mercan; Ahmet Eftal Yucel; Gulderen Yanikkaya Demirel
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

Review 3.  Triggering agents and microbiome as environmental factors on Behçet's syndrome.

Authors:  Gonca Mumcu; Haner Direskeneli
Journal:  Intern Emerg Med       Date:  2018-12-06       Impact factor: 3.397

4.  Behçet's Uveitis: Current Diagnostic and Therapeutic Approach

Authors:  Pınar Çakar Özdal
Journal:  Turk J Ophthalmol       Date:  2020-06-27

5.  The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors.

Authors:  Merve İris; Ezgi Özçıkmak; Aysun Aksoy; Fatma Alibaz-Öner; Nevsun İnanç; Tülin Ergun; Haner Direskeneli; Gonca Mumcu
Journal:  Eur J Rheumatol       Date:  2018-10-12

6.  Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Authors:  Yutaro Soejima; Yohei Kirino; Mitsuhiro Takeno; Michiko Kurosawa; Masaki Takeuchi; Ryusuke Yoshimi; Yumiko Sugiyama; Shigeru Ohno; Yukiko Asami; Akiko Sekiguchi; Toshihisa Igarashi; Shohei Nagaoka; Yoshiaki Ishigatsubo; Hideaki Nakajima; Nobuhisa Mizuki
Journal:  Arthritis Res Ther       Date:  2021-02-01       Impact factor: 5.156

7.  Does illness perception associate with disease symptoms in Behçet's disease?

Authors:  Gonca Mumcu; Fedayi Yağar; Fatma Alibaz-Öner; Nevsun İnanç; Haner Direskeneli; Tulin Ergun
Journal:  Intern Emerg Med       Date:  2018-11-30       Impact factor: 3.397

Review 8.  Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease.

Authors:  H Direskeneli
Journal:  Genet Res Int       Date:  2013-12-31

Review 9.  Behçet's disease in children, an overview.

Authors:  Isabelle Koné-Paut
Journal:  Pediatr Rheumatol Online J       Date:  2016-02-18       Impact factor: 3.054

Review 10.  Oral Health and Its Aetiological Role in Behçet's Disease.

Authors:  Gonca Mumcu; Farida Fortune
Journal:  Front Med (Lausanne)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.